Skip to search formSkip to main contentSkip to account menu

NSC 601316

Known as: NSC-601316 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

DACA, acridine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1997
1997
Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
This study reports on the biodistribution and metabolism of the 11C-labeled novel antitumor agent N-[2-(dimethylamino)ethyl… 
1994
1994
Methadone: a potent inhibitor of rat liver aldehyde oxidase.
1991
1991
Cytosol mediated metabolism of the experimental antitumor agent acridine carboxamide to the 9-acridone derivative.
1990
1990
Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)